Author/Authors :
Djuričić Goran J. نويسنده Department of Diagnostic Imaging, University Childrens Hospital, University of Belgrade, Belgrade, Serbia , Vasiljević Jelena S. نويسنده Institute “Mihajlo Pupin”, University of Belgrade, Belgrade, Serbia , Ristić Dušan J. نويسنده Institute of Oncology & Radiology of Serbia, Belgrade, Serbia , Kovačević Relja Z. نويسنده Institute of Pathology, School of Medicine, University of Belgrade, Belgrade, Serbia , Ristić Dalibor V. نويسنده The School of Computing, University Union, Belgrade, Serbia , Milosević Nebojša T. نويسنده Department of Biophysics, School of Medicine, University of Belgrade, Belgrade, Serbia , Radulovic Marko نويسنده Institute of Oncology & Radiology of Serbia, Belgrade, Serbia , Sopta Jelena P. نويسنده Institute of Pathology, School of Medicine, University of Belgrade, Belgrade, Serbia
Abstract :
[Background]Due to the high level of cytogenetic heterogeneity in osteosarcoma, personalized treatment is the promising strategy for the improvement in outcomes. This is currently not possible due to the absence of targeted therapies and reliable predictors for response to induction chemotherapy.[Objectives]To investigate the predictive value of computational analysis of osteosarcoma magnetic resonance (MR) images.[Patients and Methods]Multifractal analysis was performed on MR images of primary osteosarcoma of long tubular bones prior to OsteoSa induction chemotherapy. A total of 900 images derived from 67 good and poor responder patients were classified and compared to the actual retrospective outcome.[Results]Among the six calculated multifractal features, Dqmax exerted the highest predictive value with the prediction accuracy of 74.3%, sensitivity of 72.4% and specificity of 76.2%. The obtained classification accuracy was validated by a ten V-fold split sample cross validation. The area under the curve (AUC) value for the best-performing multifractal Dqmax feature was 0.82 (95% confidence interval, 0.70 - 0.91).[Conclusion]These results suggest for the first time that measuring tumor structure by using multifractal geometry can predict an individual patient response to neoadjuvant cytotoxic therapy. Therefore, it potentially allows precise implementation of alternative treatment options. This predictive approach made use of digital data that is routinely collected but currently still underexploited.
